Skip Navigation


Journal of the National Cancer Institute Advance Access originally published online on April 29, 2008
JNCI Journal of the National Cancer Institute 2008 100(9):607-610; doi:10.1093/jnci/djn132
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
100/9/607    most recent
djn132v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Lipscomb, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lipscomb, J.
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Published by Oxford University Press 2008.

EDITORIALS

Estimating the Cost of Cancer Care in the United States: A Work Very Much in Progress

Joseph Lipscomb

Affiliation of author: Department of Health Policy and Management, Rollins School of Public Health and Winship Cancer Institute, Emory University, Atlanta, GA

Correspondence to: Joseph Lipscomb, PhD, Department of Health Policy and Management, Rollins School of Public Health, Emory University, Room 642, 1518 Clifton Road North East, Atlanta, GA 30322 (e-mail: jlipsco@sph.emory.edu).

The first 150 words of the full text of this article appear below.

There are many important uses for conceptually sound, empirically strong estimates of cancer care costs. Such uses include assessment of the aggregate economic burden of cancer at the national, state, or local level; economic evaluation of cancer interventions by such approaches as cost-effectiveness analysis; and delineation of the cost of specific cancer interventions at the individual patient level to support informed patient and physician decision making (1).

There are also many viable ways to produce such cancer cost estimates (2). Analysts must decide on the scope of the analysis (eg, national or patient level); its cancer focus (eg, one or several tumor sites or all cancers); data sources (eg, cancer registries, insurance claims, patient surveys, or medical records); perspective regarding who bears the cost burden (eg, the patient, third-party payer, or society at large); cost flow time frame (eg, prevalence costs in a specific year for . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

Cost of Care for Elderly Cancer Patients in the United States
K. Robin Yabroff, Elizabeth B. Lamont, Angela Mariotto, Joan L. Warren, Marie Topor, Angela Meekins, and Martin L. Brown
J Natl Cancer Inst 2008 100: 630-641. [Abstract] [Full Text] [PDF]

IN THIS ISSUE
J Natl Cancer Inst 2008 100: 603. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 Lab MedHome page
B. Handy
The Clinical Utility of Tumor Markers
Lab Med, February 1, 2009; 40(2): 99 - 103.
[Abstract] [Full Text] [PDF]